AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond

Christopher Raymond, Piper Sander senior biotech analyst, joins 'Power Lunch' to discuss what it means for biotech companies to be defensive, Raymond's thoughts around Abbvie and if biotech companies have hit a bottom.

By: CNBC Television
Title: AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond
Sourced From: www.youtube.com/watch?v=SqzB2lTMjbw

News.... browse around here

Trading News: https://branch.centuryac.com/qcnfl/celebrities-who-disc-golf.html

Exciting Finds: Zet news roundup

Stay up to date on China: https://www.chinapulse.com/data-news/2021/05/21/jd-logistics-raises-3-16-billion-in-hong-kong-ipos-reuters/

Florida rehab centers key to reducing overdose deaths

Output QR Code